B cell abnormalities in Wegener's granulomatosis and microscopic polyangiitis: Role of CD25+-expressing B cells

Journal of Rheumatology

Volumn 37, Issue 10, 2010, Pages 2086-2095

  Eriksson, Per ^a   Sandell, Christina ^a   Backteman, Karin ^a   Ernerudh, Jan ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antineutrophil cytoplasmic antibodies; B cells; CD25; Vasculitis

Indexed keywords

AZATHIOPRINE; CD19 ANTIGEN; CD20 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; CD86 ANTIGEN; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN D; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB;

ADULT; AGED; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CD25+ T LYMPHOCYTE; CELL MATURATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LOW DRUG DOSE; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MALE; MICROSCOPIC POLYANGIITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REMISSION; VASCULITIS; WEGENER GRANULOMATOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; B-LYMPHOCYTES; FEMALE; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE SUBSETS; MALE; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; WEGENER GRANULOMATOSIS;

EID: 77957865413     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.100074     Document Type: Article

References (36)

1. Eriksson P. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab. J Intern Med 2005;257:540-8.
2. Jones R, Ferraro A, Chaudhry A, Brogan P, Salama A, Smith K, et al. A multicenter survey of rituximab therapy for refractory antineutrophil cyoplasmic antibody-associated vasculitis. Arthritis Rheum 2009;60:2156-68.
3. Jamin C, Morva A, Lemoine S, Daridon C, de Mendoza AR, Youinou P. Regulatory B lymphocytes in humans. A potential role in autoimmunity. Arthritis Rheum 2008;58:1900-6.
4. Pascual V, Liu YJ, Magalski A, de Bouteiller O, Banchereau J, Capra JD. Analysis of somatic mutation in five B cell subsets of human tonsil. J Exp Med 1994;180:329-39.
5. Frazer JK, LeGros J, Bouteiller O, Liu YJ, Banchereau J, Pascual V, et al. Identification and cloning of genes expressed by human tonsillar B lymphocyte subsets. Ann NY Acad Sci 1997;815:316-8.
6. Bonhorst J, Bjorgan M, Thoen J, Natvig J, Thompson K. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren's syndrome. J Immunol 2001;167:3610-8.
7. Liu YJ, Arpin C. Germinal center development. Immunol Rew 1997;156:111-26.
8. Brisslert M, Bokarewa M, Larsson P, Wing K, Collins LV, Tarkowski A. Phenotypic and functional characterization of human CD25+ B cells. Immunology 2006;117:548-57.
9. Tretter T, Venigalla R, Eckstein V, Saffrich R, Sertel S, Ho A, et al. Induction of CD4+ T-cell anergy and apoptosis by activated human B cells. Blood 2008;112:4555-64.
10. Mizogushi A, Bhan A. A case for regulatory B cells. J Immunol 2006;176:705-10.
11. Amu S, Tarkowski A, Dörner T, Bokarewa M, Brisslert M. The human immunmodulatory CD25+ B cell population belongs to the memory B cell pool. Scand J Immunol 2007;66:77-86.
12. Hillion S, Saraux A, Youinou P, Jamin C. Expression of RAGs in peripheral B cells outside germinal centers is associated with the expression of CD5. J Immunol 2005;174:5553-61.
13. Böhm I. Increased peripheral blood B-cells expressing the CD5 molecules in association to autoantibodies in patients with lupus erythematosus and evidence to selectively down-modulate them. Biochem Pharmacother 2004;58:338-43.
14. Vernino L, Pisetsky D, Lipsky P. Analysis of the expression of CD5 by human B cells and correlation with functional activity. Cell Immunol 1992;139:185-97.
15. Berden A, Kallenberg C, Savage C, Yard B, Abdulahad W, de Heer E, et al. Cellular immunity in Wegener's granulomatosis. Characterizing T lymphocytes. Arthritis Rheum 2009;60:1578-87.
16. Popa E, Stegeman C, Bos N, Kallenberg C, Tervaert J. Differential B- and T-cell activation in Wegener's granulomatosis. J Allergy Clin Immunol 1999;103:885-94.
17. Jenette J, Falk R, Andrassy K, Bacon P, Churg J, Gross W, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
18. Luqmani R, Exley A, Kitas G, Bacon P. Disease assessment and management of the vasculitides. Baillière's Clin Rheumatol 1997;11:423-44.
19. Jayne D, Rasmussen N. Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group. Mayo Clin Proc 1997;72:737-47.
20. Waldmann T, Goldman C, Robb RJ, Depper J, Leonard W, Sharrow S, et al. Expression of interleukin 2 receptors on activated human B cells. J Exp Med 1984;160:1450-66.
21. Amu S, Strömberg K, Bokarewa M, Tarkowski A, Brisslert M. CD25-expressing B-lymphocytes in rheumatic diseases. Scand J Immunol 2007;65:182-91.
22. Douglas RS, Gianoukakis AG, Goldberg RA, Kamat S, Smith TJ. Circulating mononuclear cells from euthyroid patients with thyroid-associated ophthalmopathy exhibit characteristic phenotypes. Clin Exp Immunol 2007;148:64-71.
23. Vincenti F. Costimulation blockade in autoimmunity and transplantation. J Allergy Clin Immunol 2008;121:299-306.
24. Greenwald R, Freeman G, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005;23:515-48.
25. Podojil J, Sanders V. Selective regulation of mature IgG1 transcription by CD86 and ß2-adrenergic receptor stimulation. J Immunol 2003;170:5143-51.
26. Moosig F, Csernok E, Wang G, Gross WL. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells. Clin Exp Immunol 1998;114:113-8.
27. Folzenlogen D, Hofer MF, Leung DY, Freed JH, Newell MK. Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients. Clin Immunol Immunopathol 1997;83:199-204.
28. Leandro M, Cambridge G, Ehrenstein M, Edwards J. Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis. Arthritis Rheum 2006;54:613-20.
29. Roll P, Dörner T, Tony H-P. Anti-CD20 therapy in patients with rheumatoid arthritis. Predictors of response and B cell subset regeneration after repeated treatment. Arthritis Rheum 2008;58:1566-75.
30. Sanz I, Wei C, Lee E-H, Anolik J. Phenotypic and functional heterogeneity of human memory B cells. Semin Immunol 2008;20:67-82.
31. Odendahl M, Jacobi A, Hansen A, Feist T, Hiepe F, Burmester GR, et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 2000;165:5970-9.
32. Arce E, Jackson DG, Gill MA, Bennett LB, Banchereau J, Pascual V. Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J Immunol 2001;167:2361-9.
33. Jacobi AM, Odendahl M, Reiter K, Bruns A, Burmester GR, Radbruch A, et al. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 2003;48:1332-42.
34. Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood 2005;105:4390-8.
35. Jacobi A, Reiter K, Mackay M, Aranow C, Hiepe F, Radbrush A, et al. Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus. Arthritis Rheum 2008;58:1762-73.
36. Hansen A, Odendahl M, Reiter K, Jacobi AM, Feist E, Scholze J, et al. Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 2002;46:2160-71.